Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.42 |
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 4/20 | 0.37 |
| ▸ | TUBB | P07437 | 4/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.37 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.37 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.37 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.37 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.37 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.37 |
| ▸ | PREP | P48147 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29951251 | 1.00 | CA1 (0.42) | CA1CA12CA9ENPP2TUBB4A | |
| SCHEMBL29953678 | 0.88 | TUBB4A (0.43) | CA1CA12CA9ENPP2TUBB4A | |
| SCHEMBL1612747 | 0.81 | CA12 (0.35) | CA1CA12CA9ENPP2PREP | |
| SCHEMBL2022605 | 0.81 | CA12 (0.44) | CA1CA12CA9PREPHSP90AA1 | |
| SCHEMBL14511843 | 0.80 | PREP (0.40) | CA1CA12CA9ENPP2TUBB4A | |
| SCHEMBL2114690 | 0.79 | CA12 (0.43) | CA1CA12CA9PREPHSP90AA1 | |
| SCHEMBL29951222 | 0.79 | CA12 (0.43) | CA1CA12CA9PREPHSP90AA1 | |
| SCHEMBL2023774 | 0.79 | CA12 (0.45) | CA1CA12CA9PREPCA2 | |
| SCHEMBL16135178 | 0.78 | TUBB4A (0.49) | CA1CA12CA9TUBB4ATUBB | |
| SCHEMBL12577662 | 0.78 | CA12 (0.44) | CA1CA12CA9PREPHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968552-B2 | Oxadiazolidinedione compound | ASTELLAS PHARMA INC. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-7968552-B2 | Oxadiazolidinedione compound | ASTELLAS PHARMA INC. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20090186909-A1 | Oxadiazolidinedione Compound | ASTELLAS PHARMA INC. (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090186909-A1 | Oxadiazolidinedione Compound | ASTELLAS PHARMA INC. (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-2011788-A1 | OXADIAZOLIDINEDIONE COMPOUND | Astellas Pharma Inc. (JP) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186909-A1 | Oxadiazolidinedione Compound | GPR119, GPR39, GPR65 | CA1 4091/4885CA12 4396/4885CA9 3645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.